We are live on ! Find out more
ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 340.85%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+340.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.7B
AUM Growth
+$337M
Cap. Flow
+$320M
Cap. Flow %
18.81%
Top 10 Hldgs %
39.64%
Holding
351
New
78
Increased
102
Reduced
60
Closed
41

Top Buys

1
BEAM icon
Beam Therapeutics
BEAM
+$40.1M
2
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$37.1M
3
DNLI icon
Denali Therapeutics
DNLI
+$36.2M
4
INSP icon
Inspire Medical Systems
INSP
+$27.3M
5
VIR icon
Vir Biotechnology
VIR
+$21.9M

Top Sells

1
RNAM
Avidity Biosciences
RNAM
+$39.4M
2
RAPT
RAPT Therapeutics
RAPT
+$17.3M
3
CDTX
Cidara Therapeutics
CDTX
+$13.2M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
ABUS icon
Arbutus Biopharma
ABUS
+$9.98M

Sector Composition

1 Healthcare 88.42%
2 Financials 1.51%
3 Technology 0.08%
4 Industrials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
301
KALA BIO
KALA
$17.7M
$24.5K ﹤0.01%
2,830
– –
CHRS icon
302
Coherus Oncology
CHRS
$216M
$17.5K ﹤0.01%
10,366
– –
PRQR icon
303
ProQR Therapeutics
PRQR
$237M
$16.2K ﹤0.01%
10,000
– –
QNCX icon
304
Quince Therapeutics
QNCX
$20M
$5.08K ﹤0.01%
251
+36
+17% +$7.23K
QNCX icon
305
PUT
Quince Therapeutics
QNCX
$20M
$5.07K ﹤0.01%
250
-150
-38% -$30.1K
AQST icon
306
PUT
Aquestive Therapeutics
AQST
$503M
– –
-254,000
Closed -$1.64M
ATXS
307
DELISTED
Astria Therapeutics
ATXS
– –
-173,557
Closed -$2.27M
AUPH icon
308
Aurinia Pharmaceuticals
AUPH
$2.04B
– –
-22,000
Closed -$351K
AVDL
309
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-150,532
Closed -$3.24M
AZN icon
310
AstraZeneca
AZN
$264B
– –
-4,500
Closed -$827K
CDTX
311
DELISTED
Cidara Therapeutics
CDTX
– –
-59,677
Closed -$13.2M
CTMX icon
312
CALL
CytomX Therapeutics
CTMX
$775M
– –
-100,000
Closed -$426K
DVAX
313
DELISTED
Dynavax Technologies
DVAX
– –
-170,000
Closed -$2.61M
DYN icon
314
CALL
Dyne Therapeutics
DYN
$3.76B
– –
-10,000
Closed -$196K
FULC icon
315
CALL
Fulcrum Therapeutics
FULC
$237M
– –
-65,000
Closed -$735K
GBIO
316
DELISTED
Generation Bio
GBIO
– –
-22,144
Closed -$126K
GOSS icon
317
CALL
Gossamer Bio
GOSS
$79.2M
– –
-35,100
Closed -$109K
GOSS icon
318
PUT
Gossamer Bio
GOSS
$79.2M
– –
-463,200
Closed -$1.44M
IDXX icon
319
Idexx Laboratories
IDXX
$45.2B
– –
-400
Closed -$271K
IMUX icon
320
Immunic
IMUX
$198M
$0 ﹤0.01%
+3,000
New +$26.9K
INO icon
321
CALL
Inovio Pharmaceuticals
INO
$93.8M
– –
-75,500
Closed -$131K
IOBT
322
DELISTED
IO Biotech
IOBT
– –
-24,964
Closed -$15.2K
IWM icon
323
iShares Russell 2000 ETF
IWM
$82.7B
– –
-12,070
Closed -$3.11M
NGNE icon
324
Neurogene
NGNE
$754M
– –
-30,633
Closed -$631K
NVCR icon
325
NovoCure
NVCR
$1.88B
– –
-34,000
Closed -$440K
10 11 12
13
14

Similar funds

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
SWM
Segment Wealth Management Houston, Texas $1.7B AUM 24.61% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM